INNATE PHARMA
CEO
CEO
INNATE PHARMA
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jonathan Dickinson is recorded as CEO at INNATE PHARMA. Jonathan Dickinson has spoken on 1 earnings call across 1 company, most recently for INNATE PHARMA on September 17, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
INNATE PHARMA
CEO
Transcript header (unverified)
Recorded roles and call appearances connecting this person to public companies.
INNATE PHARMA
CEO
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Publication of half year financial statements
INNATE PHARMA